Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Cash & Equivalents (2021 - 2026)

Envoy Medical's Cash & Equivalents history spans 5 years, with the latest figure at $25.3 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 375.36% to $25.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $25.3 million, a 375.36% increase, with the full-year FY2025 number at $3.7 million, down 31.81% from a year prior.
  • Cash & Equivalents hit $25.3 million in Q1 2026 for Envoy Medical, up from $3.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for COCH hit a ceiling of $25.3 million in Q1 2026 and a floor of $68000.0 in Q2 2023.
  • Historically, Cash & Equivalents has averaged $5.2 million across 5 years, with a median of $4.0 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: surged 5476.21% in 2023 and later crashed 73.73% in 2024.
  • Tracing COCH's Cash & Equivalents over 5 years: stood at $183000.0 in 2022, then soared by 2205.46% to $4.2 million in 2023, then increased by 29.96% to $5.5 million in 2024, then crashed by 31.81% to $3.7 million in 2025, then skyrocketed by 575.34% to $25.3 million in 2026.
  • Business Quant data shows Cash & Equivalents for COCH at $25.3 million in Q1 2026, $3.7 million in Q4 2025, and $3.6 million in Q3 2025.